Antidote Technologies, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Antidote Technologies, Inc. - overview
Established
2010
Location
London, -, UK
Primary Industry
Healthcare
About
Based in London, UK, and founded in 2010 by Eithan Ephrati, Jessica Mann, and Pablo Graiver, Antidote Technologies, Inc. , a. k. a.
Antidote operates as a health-tech company that uses precision recruitment to match the right patients with the right trials through the integration of data-driven technologies, domain experience, digital expertise, diverse partner network, and personalized patient and site services. In June 2021, Antidote Technologies, Inc. raised USD 23. 2 million in venture funding led by LBO France, with participation from Merck Global Health Innovation Fund, Octopus Ventures, and Smedvig Capital.
As of June 2021, Laurent Schockmel is the CEO of the company. Antidote's primary product is a platform that facilitates the vital connections between patients and clinical trials. The company uses precision recruitment to match the right patients with the right trials to strike the right balance between technology and human touch to deliver patient engagement. This solution serves as a crucial link, enabling patients to access and participate in clinical research that can have an impact on their lives.
By addressing the challenge of patient recruitment, Antidote is streamlining the process and accelerating medical advancements.
Current Investors
Amadeus Capital Partners, Smedvig Capital, Merck Global Health Innovation Fund
Primary Industry
Healthcare
Sub Industries
Recruitment/Executive Search, Healthcare
Website
www.antidote.me
Verticals
HealthTech
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.